Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Depreciation & Amortization (CF): 2022-2025

Historic Depreciation & Amortization (CF) for Roivant Sciences (ROIV) over the last 4 years, with Mar 2025 value amounting to $14.1 million.

  • Roivant Sciences' Depreciation & Amortization (CF) fell 80.98% to $921,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $19.5 million, marking a year-over-year decrease of 39.27%. This contributed to the annual value of $14.1 million for FY2025, which is 36.15% down from last year.
  • According to the latest figures from FY2025, Roivant Sciences' Depreciation & Amortization (CF) is $14.1 million, which was down 36.15% from $22.0 million recorded in FY2024.
  • In the past 5 years, Roivant Sciences' Depreciation & Amortization (CF) registered a high of $22.0 million during FY2024, and its lowest value of $5.9 million during FY2022.
  • Over the past 3 years, Roivant Sciences' median Depreciation & Amortization (CF) value was $18.9 million (recorded in 2023), while the average stood at $18.3 million.
  • Per our database at Business Quant, Roivant Sciences' Depreciation & Amortization (CF) soared by 217.89% in 2023 and then crashed by 36.15% in 2025.
  • Over the past 4 years, Roivant Sciences' Depreciation & Amortization (CF) (Yearly) stood at $5.9 million in 2022, then spiked by 217.89% to $18.9 million in 2023, then increased by 16.86% to $22.0 million in 2024, then slumped by 36.15% to $14.1 million in 2025.